作者: Peter K. Sorger , Birgit Schoeberl
关键词:
摘要: The profound challenges facing clinicians, who must prescribe drugs in the face of dramatic variability response, and pharmaceutical industry, which develop new despite ever-rising costs, represent opportunities for cell biologists interested rethinking conceptual basis pharmacology drug discovery. Much better understanding is required quantitative behaviors networks targeted by cells, tissues, organisms. Cell these topics should learn more about basic structure development campaigns hone their programming skills. A world engaging industry-academic collaborations awaits, all with promise delivering real benefit to patients strained healthcare systems.